The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients
Abstract
CONTEXT: Adrenocortical carcinomas (ACC) are rare tumors with a poor prognosis. Few reports concerning large and homogeneous series are available. OBJECTIVE: We aimed to determine the clinical characteristics and outcome of ACC and to identify prognostic factors. DESIGN AND SETTING: This study is a descriptive and multivariate analysis of a cohort from a single endocrinology center. PATIENTS: A total of 202 consecutive patients with ACC were studied. RESULTS: The sex ratio (female to male) was 2.7. Mean age at diagnosis was 44 +/- 16 yr (range, 11-88 yr). We found that 154 patients (76%) had hypersecreting tumors [mostly cortisol and androgens (47%), cortisol alone (27%), or androgens alone (6%)] and 43 patients (21%) had metastases at diagnosis. At initial staging or during follow-up, 85 patients (42%) had liver metastases, 79 patients (39%) had lung metastases, and 20 patients had bone metastases (10%). The survival rate was 37% at 5 yr. Multivariate analysis identified the following independent prognostic factors associated with shorter survival: older age at diagnosis [hazard ratio (HR), 1.03; P < 0.0001], initial MacFarlane extension stages 3 (HR, 4.42; P = 0.005) and 4 (HR, 7.93; P < 0.0001), and cortisol hypersecretion (HR, 3.90; P < 0.0001). Treatment with 1,1-dichlorodiphenildichloroethane (o,p'DDD) in the 3 months after surgery increased the survival rate of patients with cortisol-secreting tumors (HR, 0.40; P = 0.04). CONCLUSION: This study highlights the better prognosis of ACC diagnosed at a noninvasive local stage, the particularly poor prognosis of patients with cortisol-secreting tumors, and the beneficial effect of o,p'DDD therapy in this subgroup of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impact of the functional status and clinical features of ACCs on survival is unclear (132,133).”
From Adrenal incidentaloma (2020) · cites this paper as [133]
In the citing paper
“Biochemically or clinically apparent adrenocortical hormone production is evident in up to 45% to 70% (9, 10, 85).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“Autonomous aldosterone secretion (which classically leads to hypertension and hypokalemia) is rare in ACC (85, 86).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“At the time of presentation, ACCs are generally large tumors, measuring on average 10 to 13 cm (9, 85, 89).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“Hypercortisolism is the most common presentation of patients presenting with hormone excess (50%–80% of hormone-secreting ACCs), causing classic symptoms including plethora, diabetes mellitus, muscle weakness/atrophy, and osteoporosis.”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
In the citing paper
“some recent studies identified cortisol production as an adverse prognostic factor (12, 85, 244).”
From Adrenocortical carcinoma (2014) · cites this paper as [85]
Citations
Cites
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt‐Rasmussen, U., Hagen, C., Jørgensen, J. O. L., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 763
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Self-citationIcard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Self-citationBerruti, A., Terzolo, M., Sperone, P., Pia, A. R., Casa, S. D., Gross, D. J., Carnaghi, C., Casali, P. G., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Self-citationHutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90219-1 · Cited by 277
Hutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90220-8 · Cited by 271
Macfarlane, D. A. (1958) · PubMed · Cited by 266
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 446
Surgical approach to patients with hypercortisolism
Kiernan, C. M., & Solórzano, C. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.12.13 · Cited by 11
Neutrophil–Lymphocyte Ratio as a Prognostic Marker in Adrenocortical Carcinoma
Solak, M., Kraljević, I., Zibar, K., Kaštelan, M., Kakarigi, L., Kaštelan, D., & Croatian ACC Study Group (2021) · Endocrine Research · doi:10.1080/07435800.2020.1870234 · Cited by 12
Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling
Lu, Q., Nie, R., Luo, J., Wang, X., & You, L. (2023) · Biomolecules · doi:10.3390/biom13010104 · Cited by 11
Laparoscopic adrenalectomy for adrenocortical carcinoma: A medico-surgical perspective
Gaujoux, S., Bertherat, J. Y., Dousset, B. E., & Groussin, L. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.07.001 · Cited by 11
Self-citationHeinze, B., Herrmann, L., Faßnacht, M., Ronchi, C. L., Willenberg, H. S., Quinkler, M. O., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0788 · Cited by 11
Adrenocortical cancer: morphological variants, immunohistochemical characteristics
Tkachuk, A. V., Тертычный, А. С., Beltsevich, D. G., Александровна, Р. А., Belousov, P. V., & Селиванова, Л. С. (2021) · Russian Journal of Archive of Pathology · doi:10.17116/patol20218302110 · Cited by 11
Cantini, G., Fei, L., Canu, L., Lazzeri, E., Sottili, M., Francalanci, M., Angelotti, M. L., Filpo, G. D., Ercolino, T., Gelmini, S., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111097 · Cited by 11
Tumores suprarrenales en la infancia
Martos‐Moreno, G. Á., Pozo‐Román, J., & Argente, J. (2013) · Anales de Pediatría · doi:10.1016/j.anpedi.2013.04.032 · Cited by 10
Tsoli, M., Daskalakis, K., Kassi, E. N., Kaltsas, G., & Tsolakis, A. V. (2021) · Biology · doi:10.3390/biology10070580 · Cited by 10
Le réseau national COMETE sur les tumeurs de la surrénale
Plouin, P., Gimenez‐Roqueplo, A., & BERTAGNA, X. Y. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32869-9 · Cited by 10
Self-citationAllegra, S., Puglisi, S., Brescia, I. V., Chiara, F., Basile, V., Calabrese, A., Reimondo, G., & Francia, S. D. (2021) · Life · doi:10.3390/life11030266 · Cited by 10
Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
Costa, R., Wesolowski, R., & Raghavan, D. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10464.x · Cited by 9
Binding of aberrant glycoproteins recognizable by Helix pomatia agglutinin in adrenal cancers
Parameswaran, R., Tan, W. B., Nga, M. E., Soon, G. S. T., Ngiam, K. Y., Brooks, S. A., Sadler, G. P., & Mihai, R. (2018) · BJS Open · doi:10.1002/bjs5.70 · Cited by 9
Preoperative Detection of Liver Involvement by Right-Sided Adrenocortical Carcinoma Using CT and MRI
Kedra, A., Dohan, A. J. J., Gaujoux, S., Sibony, M., Jouinot, A., Assié, G., Groussin, L., Libé, R., Bertherat, J. Y., Soyer, P. A., et al. (2021) · Cancers · doi:10.3390/cancers13071603 · Cited by 9
Self-citationCurrent issues in the diagnosis and management of adrenocortical carcinomas
Kassi, E. N., Kaltsas, G., Zografos, G., & Chrousos, G. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.6 · Cited by 9
Advances in the medical management of Cushing's syndrome
Giraldi, F. P., & Cavagnini, F. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.14.2423 · Cited by 9
Foetal exposure to mitotane/Op'DDD: Post‐natal study of four children
Magkou, D., Cao, C. D., Bouvattier, C., Douillard, C., de Marcellus, C., Cazabat, L., Gérard, M., Raffin-Sanson, M., & Young, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13854 · Cited by 10
A Pregnant Patient with Adrenocortical Carcinoma: Case Report
Kotteas, E. A., Ioachim, E., & Pavlidis, N. A. (2012) · Onkologie · doi:10.1159/000341830 · Cited by 10
Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience
Pan, L.-H., Yen, C., Huang, C.-J., Ng, X.-N., & Lin, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134643 · Cited by 8
Lin, R., Chao, Y., Lien, W., Chang, H., Tsai, S.-W., & Wang, C. (2023) · Oncology Reports · doi:10.3892/or.2023.8604 · Cited by 8
Kouyama, R., Hiraishi, K., Sugiyama, T., Izumiyama, H., Yoshimoto, T., Akashi, T., Kihara, K., Homma, K., Shibata, H., & Hirata, Y. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-026 · Cited by 8
Alghulayqah, A., ALGhasab, N. S., Amin, T., Alkahtani, N. S., Farhat, R., & Alzahrani, A. S. (2017) · Medicine · doi:10.1097/md.0000000000006751 · Cited by 8
Incidental adrenal masses - A primary care approach.
Gendy, R., & Rashid, P. (2017) · PubMed · Cited by 8
Higher SUVmax on FDG-PET is associated with shorter survival in adrenocortical carcinoma
Wrenn, S. M., Moore, A. L., Shah, H. J., Barletta, J. A., Vaidya, A., Kilbridge, K. L., Doherty, G. M., Jacene, H. A., & Nehs, M. A. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.08.020 · Cited by 8
Corticosurrénalome : nouveautés en 2014
Libé, R., & Assié, G. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.009 · Cited by 8
Huang, C.-J., Wang, T., Lo, Y., Hou, K.-T., Won, J. G. S., Jap, T., & Kuo, C. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-405 · Cited by 9
Haissaguerre, M., Louiset, E., Juhlin, C. C., Stenman, A., Laurent, C., Trouette, H., Lefèbvre, H., & Tabarin, A. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad025 · Cited by 7
Schiavon, A., Saba, L., Evaristo, C., Petiti, J., Pignochino, Y., Ferrero, G., Giordano, G., Tucciarello, C., Puglisi, S., Reimondo, G., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117917 · Cited by 7
Metastatic adrenal cortical carcinoma to T12 vertebrae
Lee, D. K., Yanamadala, V., Shankar, G. M., & Shin, J. H. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.009 · Cited by 7
Surgical treatment of potentially primary malignant adrenal tumors: an unresolved issue
Zografos, G. N., Perysinakis, I., Kyrodimou, E., Kassi, E. N., & Kaltsas, G. (2015) · HORMONES · doi:10.1007/bf03401380 · Cited by 7
The prognostic significance of adrenocortical carcinomas identified incidentally
Rossfeld, K. K., Maithel, S. K., Prescott, J. D., Wang, T. S., Fields, R. C., Weber, S. M., Sicklick, J. K., Yopp, A. C., Duh, Q., Solórzano, C. C., et al. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25274 · Cited by 7
David, S. O., Krieg, S., Esposito, I., Schott, M., Giesel, F. L., Roderburg, C., Loosen, S. H., Luedde, T., Knoefel, W. T., & Krieg, A. H. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2042-2431 · Cited by 7
Saito, T., Tojo, K., Furuta, N., Ono, K., Sasano, H., & Utsunomiya, K. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4968 · Cited by 7
Adrenal cortical carcinoma mimicking early severe preeclampsia
Jarvis, E., & Morton, A. (2013) · Obstetric Medicine · doi:10.1177/1753495x13502958 · Cited by 7
Feminizing Adrenocortical Carcinoma with Distinct Histopathological Findings
Hatano, M., Takenaka, Y., Inoue, I., Homma, K., Hasegawa, T., Sasano, H., Awata, T., & Katayama, S. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5912 · Cited by 7
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma
Xiao, H., He, W., Chen, P., Xu, D., Zeng, G., Li, Z. Y., Huang, M., Wang, X., DiSanto, M. E., & Zhang, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00472 · Cited by 7
Bronswijk, M. J., Laenen, A., & Bechter, O. E. (2019) · Neoplasma · doi:10.4149/neo_2019_190105n17 · Cited by 7
Tabarin, A., Bardet, S., Bertherat, J. Y., Chabre, O., Dupas, B., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Rohmer, V., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.002 · Cited by 7
Self-citationZhang, F., Liu, Z., Liang, J., Liu, S., Wu, K., Zhang, F., Zhou, C., Lu, Y., Zhu, Y., & Wang, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08689-5 · Cited by 7
Guarnotta, V., Stigliano, A., Terzolo, M., & Arnaldi, G. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09989-y · Cited by 6
Spanish consensus on the diagnosis and management of adrenocortical carcinoma
Castro, M. A., Álvarez-Escolá, C., Casteràs, A., Carmona‐Bayonas, A., Chiara, M., Hanzu, F. A., Hernando, J., Vercher-Conejero, J. L., Rodríguez‐Fraile, M., Santos, V. G. D., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-25-0034 · Cited by 7
Coste, J., Tissier, F., Pouchot, J., Écosse, E., Rouquette, A., BERTAGNA, X. Y., Libé, R., & Viallon, V. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.02.004 · Cited by 6
Self-citationMelero, V. M. A., García-Centeno, R., Bayort, J., Vigovich, C., García-Cervigón, P. S., & Albarrán, A. J. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72970-5 · Cited by 6
Proteome analysis of adrenal cortical tumors
Kim, H. M., Lee, Y. K., & Koo, J. S. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1210008 · Cited by 6
Garay-Lechuga, D., Pérez-Soto, R. H., Hernández-Acevedo, J. D., Butrón-Hernández, D., Sierra‐Salazar, M., Pantoja‐Millán, J. P., Herrera, M. F., & Velázquez‐Fernández, D. (2021) · Surgery · doi:10.1016/j.surg.2021.04.042 · Cited by 6
Incidentalomes de la glande surrénale : ne pas méconnaître les tumeurs à risque
Tabarin, A. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.006 · Cited by 6
Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma
Jong, M. C. D., Patel, N., Hassan-Smith, Z. K., Mihai, R., & Khan, S. (2021) · Endocrine Research · doi:10.1080/07435800.2021.1954942 · Cited by 6
Ide, H., Terado, Y., Tokiwa, S., Nishio, K., Saito, K., Isotani, S., Kamiyama, Y., Muto, S., Imamura, T., & Horie, S. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq045 · Cited by 6
Resektionsstrategie bei Nebennierenrindenkarzinomen
Schimmack, S. J., & Strobel, O. (2018) · Der Chirurg · doi:10.1007/s00104-018-0712-4 · Cited by 6
Harada, K., Yasuda, M., Hasegawa, K., Yamazaki, Y., Sasano, H., & Otsuka, F. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0067 · Cited by 6
The diagnosis and treatment of adrenocortical carcinoma in pregnancy: a case report
Zhang, Y., Yuan, Z., Qiu, C., Li, S., Zhang, S., & Fang, Y. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2737-1 · Cited by 7
Perna, V., Taylor, N., Dorota Dworakowska, B., Schulte, K., Aylwin, S. J. B., Al‐Hashimi, F., & Díaz‐Cano, S. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12458 · Cited by 6
Surgery of adrenocortical cancer
Harrison, B. J. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.003 · Cited by 6
Ronchi, C. L., Sbiera, S., Leich, E., Rosenwald, A., Allolio, B., & Faßnacht, M. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.32.oc4.2 · Cited by 6
Clinical and Histopathological Variables and Prognostic Factors of Adrenocortical Carcinoma
Sohail, S., Azmat, U., Khawaja, S. N., Mir, K., Azam, M., Syed, M., Mushtaq, S., Hassan, U., Siddiqui, A., Raza, S. A., et al. (2021) · Cureus · doi:10.7759/cureus.15721 · Cited by 5
ALTIERI, B., Lalli, E., & Faggiano, A. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03601-0 · Cited by 5
Wang, R., Solomon, B., Luen, S. J., Prall, O. W. J., Khoo, C., Gill, A. J., Lewin, J. H., & Sachithanandan, N. (2022) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0081 · Cited by 7
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes
Brönimann, S., Garstka, N., & Mesut Remzi, A. (2022) · Current Opinion in Urology · doi:10.1097/mou.0000000000001045 · Cited by 5
Rosenberg, R. C., Raeburn, C. D., Clay, M. R., & Wierman, M. E. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad073 · Cited by 5
Steroid profiling in adrenal disease
Mu, D., Sun, D., Qian, X., Ma, X., Qiu, L., Cheng, X., & Yu, S. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117749 · Cited by 5
Brutsaert, E. F., Sasano, H., Unger, P. D., Beasley, M. B., Golden, B. K., Inabnet, W. B., & Levine, A. C. (2012) · Endocrine Practice · doi:10.4158/ep12018.cr · Cited by 5
Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature
Jonker, P., Meyer, V., & Kruijff, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.009 · Cited by 5
Adrenal Causes of Hypercortisolism
Cavagnini, F., & Giraldi, F. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00102-7 · Cited by 5
Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours
Maity, P., Mondal, A., Das, R., Sengupta, M., Gargari, P., Kar, A., Sarkar, D., Mukhopadhyay, S., Chowdhury, S., & Chatterjee, U. (2022) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_153_21 · Cited by 5
The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors
Chortis, V. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02869-9 · Cited by 5
Repeated resections for liver metastasis from primary adrenocortical carcinoma: A case report
Nakano, R., Satoh, D., Nakajima, H., 吉村, 友., Miyoshi, H., Yoshida, K., Matsukawa, H., Shiozaki, S., Ichimura, K., Okajima, M., et al. (2015) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2015.02.041 · Cited by 5
Allolio, B., & Faßnacht, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00106-4 · Cited by 5
Barat, M., Eltaher, M., Moawad, A. W., Soyer, P. A., Fuentes, D., Golse, M., Jouinot, A., Ahmed, A. A., Shehata, M., Assié, G., et al. (2025) · Canadian Association of Radiologists Journal · doi:10.1177/08465371251335170 · Cited by 4
Self-citationBonnet-Serrano, F., Thomeret, L., Benanteur, N., Vaduva, P., Violon, F., Bouys, L., Ragazzon, B., Berthon, A. S., Perlemoine, K., Wilmot-Roussel, H., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf129 · Cited by 4
Self-citationArakawa, Y., Elloumi, F., Varma, S., Khandagale, P., Jo, U., Kumar, S., Roper, N., Reinhold, W. C., Robey, R. W., Takebe, N., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0100 · Cited by 4
Yamazaki, Y., Tezuka, Y., Ono, Y., Satoh, F., Sasano, H., & Suzuki, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0466 · Cited by 4
Adrenal Cortex Tumors and Hyperplasias
Pignatelli, D. (2011) · InTech eBooks · doi:10.5772/19108 · Cited by 4
Palter, V. N., Devon, K. M., Hallet, J. I., Kulkarni, G. S., Law, C., & Urbach, D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-26276-5_1 · Cited by 4
Oncocytic Adrenocortical Carcinoma in a Young Patient
Singh, Y. (2022) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2022.383 · Cited by 4
Deng, J., Wei, L., Fan, Q., Wu, Z., & Ji, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1157740 · Cited by 4
Logan, C. D., Nunnally, S. E. A., Valukas, C. S., Warwar, S., Swinarska, J. T., Lee, F. T., Bentrem, D. J., Odell, D. D., Elaraj, D. M., & Sturgeon, C. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27387 · Cited by 5
A case report of neurological adverse events caused by short-term and low-dose treatment of mitotane
Liu, X., Fu, Q., Tang, Y., Deng, J., Mei, D., & Zhang, B. (2020) · Medicine · doi:10.1097/md.0000000000022620 · Cited by 4
Adrenocortical carcinoma: Retrospective analysis of the last 22 years
Guelho, D., Paiva, I., Vieira, A., & Carrilho, F. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.12.009 · Cited by 4
Estrogen-secreting adrenocortical carcinoma
Jeong, Y. C., Cho, S. C., Cho, H. J., Song, J. S., Kong, J. S., Park, J. W., & Ku, Y. H. (2018) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2019.00017 · Cited by 4
Chopra, S., Shukla, J., Purohit, P., Adhikari, U., Roesch, F., Moon, E., Rathore, Y., Rana, N., Bhadada, S., Mittal, B., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07203-4 · Cited by 2
Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma
Huang, J., Sun, C., Zhang, T., Pan, L., Wang, S., He, Q., & Li, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-2063-1 · Cited by 3
RetractedRao, S. N., & Habra, M. A. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0247-9 · Cited by 3
Adrenocortical Carcinoma - A 25 Years Tertiary Centre Experience and Short Review of the Literature
Nunes, J. M. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00148 · Cited by 3
Abas, K., Gomez, M. H. S., Mapanao-Gonong, J., & Arellano, R. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.02.10 · Cited by 3
Androgen- and cortisol-secreting adrenocortical adenoma may also be “subdinical”
Ambrosi, B., Costa, E., & Bonavina, L. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346374 · Cited by 3
An Unusual Cause of Mineralocorticoid Hypertension
Freel, E. M., Perry, C. G., O’Dwyer, P., Staessen, J. A., Jennings, G., Granger, J. P., Buyzere, M. D., & Schiffrin, E. L. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04401 · Cited by 3
A current perspective on treatment of adrenocortical carcinoma
Terzolo, M., Francia, S. D., Ardito, A., Perotti, P., Ferrari, L., & Berruti, A. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.931222 · Cited by 3
Corticosurrénalome et grossesse
Raffin‐Sanson, M., Abiven, G., Ritzel, K., de Corbière, P., Cazabat, L., Zaharia, R., Groussin, L., Libé, R., Bertherat, J. Y., Faßnacht, M., et al. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.04.024 · Cited by 3
Self-citationEttaieb, M. H. T. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201218me · Cited by 4
Murvelashvili, N., Polanco, P. M., Khorsand, S., Marrero, J. A., Jia, L., Mirfakhraee, S., Else, T., Habra, M. A., Cole, S., & Hamidi, O. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac101 · Cited by 3
Imaging of Adrenocortical Carcinoma: An Update
Howard, B., Elsayed, A., Klimkowski, S., Lee, J. T., & Elsayes, K. M. (2024) · Seminars in Roentgenology · doi:10.1053/j.ro.2024.11.005 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2025.07.003 · Cited by 2
Giner, I. S., Resende, J. S. D. S., Muzzi, J. C. D., Barbuto, J. A. M., Lalli, E., Castro, M., & de Figueiredo, B. C. (2026) · Cancers · doi:10.3390/cancers18020229 · Cited by 2
Chirurgische Strategien beim nichtmetastasierten Nebennierenrindenkarzinom
Rayes, N., Quinkler, M. O., & Denecke, T. (2018) · Der Chirurg · doi:10.1007/s00104-017-0582-1 · Cited by 2
Exploratory Circular RNA Profiling in Adrenocortical Tumors
Turai, P. I., Nyírő, G., Borka, K., Micsík, T., Likó, I., Patócs, A., & Igaz, P. (2022) · Cancers · doi:10.3390/cancers14174313 · Cited by 2
The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma
Baek, S. K., Lee, S. H., Park, S. S., Ahn, C. H., Kong, S. H., Kim, W. W., Lee, Y.-M., Kim, S. J., Song, D. E., Sung, T., et al. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2086 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2024) · Advances in Oncology · doi:10.1016/j.yao.2024.11.003 · Cited by 2
Pfeffer, A., Beke, N., Bakó, D., Hernádfői, M., Kói, T., Fogarasi, A., Párniczky, A., Hegyi, P. J., & Garami, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf457 · Cited by 2
THE GRIEVING RESPONSE OF CERVICAL CANCER PATIENTS IN A REFERRAL HOSPITAL IN BANDUNG CITY
Nuruliani, A., Sriati, A., & Hermayanti, Y. (2019) · Journal of Maternity Care and Reproductive Health · doi:10.36780/jmcrh.v2i1.62 · Cited by 2
Metadata
- Authors
- Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J.
- Affiliations
- Hôpital Cochin (FR)
- Centre National de la Recherche Scientifique (FR)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07
- Volume
- 91
- Issue
- 7
- Pages
- 2650-2655
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140991656
- Cited by
- 435
- References
- 34
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 14 · 2023: 23 · 2022: 20 · 2021: 30 · 2020: 25 · 2019: 23 · 2018: 33 · 2017: 17 · 2016: 23 · 2015: 32 · 2014: 31 · 2013: 21 · 2012: 18
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenocortical carcinoma, prognosis, prognostic factors, survival, liver metastasis, lung metastasis, age at diagnosis, mitotane, adjuvant chemotherapy, androgen-secreting tumor
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Analysis of Variance, Androgens, Bone Neoplasms, Female, Humans, Hydrocortisone, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Mitotane, Neoplasm Staging, Prognosis, Survival Rate, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
